RxDoctor Payments Data

Bozena Wrobel, MD

Otolaryngology · Los Angeles, CANPI 1457378168

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $11,125 of the $12,535 with a category attached, or 88.7%. Optinose US, Inc. accounts for 83.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $5,062 and has fallen 69.8% since, to $1,531 in 2025. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,535in general payments, 2019–2025

Across 22 payments — averaging $569.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$10K
  • Medtronic$2K
  • Acclarent, Inc$206
  • Intersect ENT, Inc.$145
  • Stryker$66
  • Paratek Pharmaceuticals, Inc.$31

What the payments were for

  • Speaking & faculty fees$11,12589%
  • Travel & lodging$1982%
  • Food & beverage$1,21210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,535 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California →

Medicare billing

Part B allowed, 2024
$151,074
Medicare patients
192
Services billed
938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →